Alpha-1-acid (AAG, Orosomucoid) glycoprotein: Interaction with bacterial lipopolysaccharide and protection from sepsis

Inflammation

Volumn 21, Issue 1, 1997, Pages 69-82

  Moore, David F ^a   Rosenfeld, Myrna R ^b   Gribbon, Philip M ^c   Winlove, C Peter ^c   Tsai, C M ^d  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE PHASE PROTEIN; BACTERIUM LIPOPOLYSACCHARIDE; CYTOKINE; ENDOTOXIN; IMMUNOMODULATING AGENT; OROSOMUCOID;

ACUTE PHASE RESPONSE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN ANTIBODY REACTION; ARTICLE; CELL ACTIVATION; CELL STIMULATION; COMPLEX FORMATION; CONTROLLED STUDY; ENTHALPY; ESCHERICHIA COLI; FEMALE; IMMUNOMODULATION; IN VITRO STUDY; INFLAMMATION; LIGHT SCATTERING; MACROPHAGE; MONOCYTE; MOUSE; NONHUMAN; PARTICLE SIZE; PROTEIN PROTEIN INTERACTION; SEPTIC SHOCK; SURVIVAL TIME;

ANIMALS; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; LEUKEMIA P388; LIPOPOLYSACCHARIDES; MACROPHAGES; MENINGOCOCCAL INFECTIONS; MICE; MICE, INBRED BALB C; OROSOMUCOID; RABBITS; SHOCK, SEPTIC; TUMOR CELLS, CULTURED;

EID: 0030912116     PISSN: 03603997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1027342909423     Document Type: Article

References (28)

1. MACLEOD, C. M., and O. J. AVERY. 1941. The occurrence during acute infections of a protein not normally present in the blood. II. Isolation and properties of the reactive proteins. J. Exp. Med. 73:183-190.
2. PEPYS, M. B. 1981. C-reactive protein fifty years on. Lancet 1:653-657.
3. PEPYS, M. B. 1996. The acute phase response and C-reactive protein. In Oxford Textbook Of Medicine, 3rd edition. Weatherall, D. J., Ledingham, J. G. G., and Warrell, D. A., editors. Oxford University Press. Oxford. United Kingdom 1527-1533.
4. KREMER, J. M., J. WILTING, and L. H. JANSSEN. 1988. Drug binding to human alpha-1-acid glycoprotein in health and disease. Pharmacol. Rev. 40:1-47.
5. ROUTLEDGE, P. A. 1989. Clinical relevance of α1-acid glycoprotein in health and disease. In α1-Acid Glycoprotein: Genetics, Biochemistry, Physiological Functions and Pharmacology. K. Schmid, editor. Alan R. Liss, Inc., New York, New York. 185-198.
6. SCHULTZ, D. R., and P. I. ARNOLD. 1990. Properties of four acute phase proteins: C-reactive protein, serum amyloid A protein, α1-acid glycoprotein, and fibrinogen. Sem. Arth. Rheum. 20:129-147.
7. ROUTLEDGE, P. A. 1986. The plasma protein binding of basic drugs. Br. J. Clin. Pharmacol. 22:499-506.
8. BREE, F., G. HOUIN, P. BARRE, R. TILLEMENT, and J. P. TILLEMENT. 1989. Binding α1-acid glycoprotein and relevant apparent volume of distribution. In α1-Acid Glycoprotein: Genetics, Biochemistry, Physiological Functions and Pharmacology. K. Schmid, editor. Alan R. Liss, Inc., New York, New York. 321-336.
9. BOUTTEN, A., M. DEHOUX, M. DESCHENES, J. D. ROUZEAU, P. N. BORIES, and G. DURAND. 1992. α1-acid glycoprotein potentiates lipopolysaccharide induced secretion of interleukin-1β, interleukin 6 and tumour necrosis factor α by human monocytes and alveolar and peritoneal macrophages. Eur. J. Immunol. 22:2687-2695.
10. LIBERT, C., P. BROUCKAERT, and W. FIERS. 1994. Protection by α1-acid glycoprotein against tumor necrosis factor-induced lethality. J. Exp. Med. 180:1571-1575.
11. GRIME, J. K. 1985. Thermodynamics, thermochemistry and calorimetry. In Analytical solution calorimetry. J. K. Grime, editor. Wiley, New York, New York. 1-29.
12. HURLEY, J. C. 1995. Endotoxemia: methods of detection and clinical correlates. Clin. Microbiol. Res. 8:268-292.
13. VAN DER SLUIJS, P., R. OOSTING, J. G. WEITERING, M. J. HARDONK, and D. K. F. MEIJER. 1985. Biliary excretion of FITC metabolites after administration of FITC labeled asialo orosomucoid as a measure of lysosomal proteolysis. Biochem. Pharmacol. 34:1399-1405.
14. KOREN, H. S., B. S. HANDWERGER, and J. R. WUNDERLICH. 1975. Identification of macrophage like characteristics in a cultured murine tumour line. J. Immunol. 114:894-897.
15. ROITT, I. 1988. Essential Immunology, 6th edition. Blackwell Scientific Publications, Oxford. 74-75.
16. CAPUTO, G. L., G. BALDWIN, G. ALPERT, J. PARSONNET, Z. A. GILLIS, G. SIBER, and G. FLEISHER. 1992. Effect of meningococcal endotoxin in a rabbit model of shock. Circulatory Shock 36:104-112.
17. GALANOS, C., M. A. FREUDENBERG, and W. REUTTER. 1979. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. U.S.A. 76:5939-5943.
18. LEHMANN, V., M. A. FREUDENBERG, and C. GALANOS. 1987. Lethal toxicity of lipopolysaccharide and tumour necrosis factors in normal and D-galactosamine treated mice. J. Exp. Med. 165:657-663.
19. SCHMID, K. 1950. Preparation and properties of an acid glycoprotein prepared from human plasma. J. Am. Chem. Soc. 72:2816-2823.
20. BOARD, P. G., I. M. JONES, and A. K. BENTLEY, 1986. Molecular cloning and nucleotide sequence of human alpha-1-acid glycoprotein cDNA. Gene 44:127-131.
21. SCHMID, K., H. KAUFMAN, S. ISEMURA, F. BAUER, J. EMURA, T. MOTOYAMA, M. ISHIGURA, and S. NANNO. 1973. Structure of alpha-1-acid glycoprotein: the complete amino acid sequence, multiple amino acid substitutions and homology with the immunoglobulins. Biochem. 12:2711-2724.
22. SCHMID, K. 1989. Human plasma α1 acid glycoprotein-biochemical properties, the amino acid sequence and the structure of the carbohydrate moiety, variant and polymorphism. In α1-Acid Glycoprotein: Genetics, Biochemistry, Physiological Functions and Pharmacology. K. Schmid, editor. Alan R. Liss Inc, New York, New York. 7-22.
23. McNAMARA, P. J., R. C. JEWELL, and M. N. GILLESPIE. 1989. The interaction of alpha-1-acid glycoprotein with endogenous autocoids, in particular, platelet activating factor (PAF). In Alpha-1-Acid Glycoprotein: Genetics, Biochemistry, Physiological Functions and Pharmacology. K. Schmid, editor. Alan R. Liss, Inc., New York, New York. 307-319.
24. LÜNDERITZ, O., C. GALANOS, and E. TH. REITSCHEL. 1986. Evolution of Gram negative bacteria. In Pharmacology of Bacterial Toxins. J. Domer and J. Drews, editors. Pergamon Press, Elmsford, New York. 307-326.
25. KIM, J. J., N. J. PHILLIPS, B. W. GIBSON, J. M. GRIFFISS, and R. YAMASAKI. 1994. Meningococcal group A lipoligosaccharides (LOS): Preliminary structural studies and characterization of serotype-associated and conserved LOS epitopes. Infect. Immun. 62:1566-1575.
26. CHAUVELOT-HOACHON, L., C. PÖUS, C. DAMAIS, F. E. LEVY, D. RAICHVARG, and J. P. GIROUD. In vivo interleukin-1 and tumour necrosis factor α are essential cytokines involved in the induction of at alpha 1-acid glycoprotein. In α1-Acid Glycoprotein: Genetics, Biochemistry, Physiological Functions and Pharmacology. K. Schmid, editor. Alan R. Liss, Inc., New York. 267-270.
27. GÖMEZ, J., V. J. HILSER, and E. FREIRE. 1995. The heat capacity of proteins. Prot. Struct. Func. Genetics. 22:404-412.
28. KEYLER, D. E., P. R. PENTEL, and D. B. HAUGHEY. 1987. Pharmacokinetics and toxicity of high dose human α1 acid glycoprotein infusion in the rat. J. Pharm. Sci. 76:101-104.